Nadal, Aquilla Loraine A.

HRN: 24-78-72  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/08/2024
OXACILLIN 500MG (VIAL)
10/08/2024
10/15/2024
SLOW IV
375 MG
Q6h
CELLULITIS AT LEFT LEG
Waiting Final Action 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes